Apellis Pharmaceuticals
APLS
#4006
Rank
NZ$3.63 B
Marketcap
$28.97
Share price
-3.66%
Change (1 day)
-63.99%
Change (1 year)

Market capitalization of Apellis Pharmaceuticals (APLS)

Market cap: NZ$3.63 Billion

As of April 2025 Apellis Pharmaceuticals has a market cap of NZ$3.63 Billion. This makes Apellis Pharmaceuticals the world's 4006th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Apellis Pharmaceuticals from 2017 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$3.63 B-49.55%
2024NZ$7.20 B-35.74%
2023NZ$11.21 B24.55%
2022NZ$9.00 B33.64%
2021NZ$6.73 B12.24%
2020NZ$6.00 B106.54%
2019NZ$2.90 B162.68%
2018NZ$1.10 B-28.04%
2017NZ$1.53 B

End of Day market cap according to different sources

On Apr 22nd, 2025 the market cap of Apellis Pharmaceuticals was reported to be:

NZ$3.63 Billion
by Nasdaq info icon info icon
NZ$3.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.61 B-82.99%๐Ÿ‡บ๐Ÿ‡ธ USA